Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

Study of MDX-1411 Given Every 14 Days With Pre-medications to Subjects With Clear Cell Kidney Cancer.

NCT00656734

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Cancer, +9 more
Locations: Beth Israel Deaconness Medical Center Boston, Massachusetts, United States

Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

Nevada Cancer Institute Las Vegas, Nevada, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing

NCT00381173

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +39 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Safety and Efficacy Study of ABX-EGF in Patients With Renal Cancer, Part 2

NCT00425035

Conditions: Advanced Renal Cell Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Not specified

View Trial Details

Completed

Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (Pharmetrics)

NCT01381601

Conditions: Adenocarcinoma, Behavior, Behavioral Symptoms, +17 more
Locations: Not specified

View Trial Details

Completed

Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (IHCIS)

NCT01381614

Conditions: Adenocarcinoma, Behavior, Behavioral Symptoms, +17 more
Locations: Not specified

View Trial Details

Completed

Safety and Tolerability Study Which Evaluate Intravesical Instillation With Mitomycin C Mixed With TC-3 Drug Retaining Hydrogel Device In Patients With Muscle Invasive Bladder Cancer

NCT01648010

Conditions: Carcinoma, Carcinoma of Urinary Bladder, Invasive, Female Urogenital Diseases, +13 more
Locations: Barzilai Hospital Ashkelon, Israel

Wolfson Holon, Israel

Beilinson Petah Tikva, Israel

View Trial Details

Completed

Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery

NCT00217542

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +27 more
Locations: Yale University New Haven, Connecticut, United States

View Trial Details

Completed

Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors

NCT00112476

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +27 more
Locations: Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors

NCT00089362

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Diseases, +142 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Chemotherapy in Treating Patients With Advanced Kidney Cancer

NCT00011973

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

Mayo Clinic Cancer Center Rochester, Minnesota, United States

University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States

University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Urologic Neoplasms

Urologic Neoplasms trial results

Related conditions